Showing results (1991-2000 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|October 18, 2016
Complementary Role of Herbal Medicine and Exercise in Cardiovascular Disease Prevention and Management: A Review of EvidenceSundar Kumar Veluswamy, Abraham Samuel Babu, Lakshmi Manickavasagam SundarCurrent Pharmaceutical Design|October 18, 2016
Convenient, Traditional and Alternative Therapies for Cardiovascular DisordersMohammad M Zarshenas, Arman Zargaran, Michael BlaschkeCurrent Pharmaceutical Design|October 21, 2016
Unravelling the Power of Omics for the Infertile Aging MalePaulo Bastos, Maria Joao Freitas, Andre Gomes, et al.Current Pharmaceutical Design|October 21, 2016
Targeting Obesity for the Prevention of Chronic Cardiovascular Disease Through Gut Microbiota-Herb Interactions: An Opportunity for Traditional HerbsFeng Chen, Jun Jiang, Dan-Dan Tian, et al.Current Pharmaceutical Design|November 2, 2016
Optimal Pre-treatment for Acute Exposure to the Organophosphate DicrotophosDietrich E Lorke, Syed M Nurulain, Mohamed Y Hasan, et al.Current Pharmaceutical Design|November 2, 2016
HDL-Targeting Therapeutics: Past, Present and FutureEmile Zakiev, Ma Feng, Vasily Sukhorukov, et al.Current Pharmaceutical Design|November 2, 2016
Therapeutic Potential of Drugs Targeting Pathophysiology of Intracerebral Hemorrhage: From Animal Models to Clinical ApplicationsKuo-Hsing Liao, Chih-Wei Sung, Ya-Ni Huang, et al.Current Pharmaceutical Design|February 8, 2014
Cardioprotection with opioids-- trusted old friends -clinical scienceHisanari IshiiCurrent Pharmaceutical Design|February 8, 2014
Anesthetic cardioprotection in clinical practice from proof-of-concept to clinical applicationsMichael Zaugg, Eliana Lucchinetti, Saeid Behmanesh, et al.Current Pharmaceutical Design|February 8, 2014
Anesthetic neuroprotection: antecedents and an appraisal of preclinical and clinical data qualityKazuyoshi Ishida, Miles Berger, Jacob Nadler, et al.Pageof 1,008